Intellectual Deficiency: Clinical Trials

1 trial for Intellectual Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Intellectual Deficiency: new trials by email Literature Review of Intellectual Deficiency trials Research Report on Intellectual Deficiency

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
MELPIDA - Spasticity, Muscle, Microcephaly
Phase 1 / Phase 2RecruitingElpida Therapeutics SPC42023-02-152026-07-08

Narrower conditions

Microcephaly (1)  ·  Muscle Spasticity (1)  ·  Paraplegia (1)

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniofacial Abnormalities (1)  ·  Malformations of Cortical Development (1)  ·  Malformations of Cortical Development, Group I (1)  ·  Muscle Hypertonia (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Abnormalities (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Nervous System Malformations (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Paralysis (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Elpida Therapeutics SPC (1)

Countries

United States (1)

Top investigators

Susan T. Iannaccone, MD, FAAN (1)

Results publications

PMID 41491634